Glucotrack (GCTK) Share-based Compensation (2010 - 2025)
Glucotrack's (GCTK) quarterly Share-based Compensation came in at $90000.0 in Q4 2025, up 236.36% YoY from $26756.8 in Q4 2024, and up 119.51% on a QoQ basis from $41000.0 in Q3 2025.
Glucotrack (GCTK) Share-based Compensation (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 16 years of Share-based Compensation data on file, last reported at $90000.0 in Q4 2025.
- Quarterly Share-based Compensation rose 236.36% year-over-year to $90000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $211000.0 (up 21.26% YoY) and the FY2025 annual result came in at $211000.0, up 21.97% from the prior year.
- Share-based Compensation rose to $90000.0 in Q4 2025, from $41000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $207000.0 in Q2 2024 to a low of -$129000.0 in Q4 2023.
- A 5-year average of $58900.0 and a median of $44000.0 in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2021 — Share-based Compensation soared 2350.0% — and 2023, when it sank 178.18%.
- Tracing GCTK's Share-based Compensation over 5 years: stood at $157000.0 in 2021, then climbed by 5.1% to $165000.0 in 2022, then slumped by 178.18% to -$129000.0 in 2023, then soared by 48.84% to -$66000.0 in 2024, then soared by 236.36% to $90000.0 in 2025.
- The last three Share-based Compensation figures came in at $90000.0 (Q4 2025), $41000.0 (Q3 2025), and $40000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.22 Bn | 129.00 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.42 Bn | 51.56 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.74 Bn | 34.39 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.89 Bn | 32.42 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 28.89 Bn | 26.21 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.07 Bn | 24.64 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.30 Bn | 14.90 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Glucotrack | 1.75 Mn | 629,179.72 | - | 59,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90,000.00 |
| Dec 31, 2025 | 90,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | -66,000.00 |
| Dec 31, 2024 | -66,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 207,000.00 |
| Jun 30, 2024 | 207,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | -129,000.00 |
| Dec 31, 2023 | -129,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Sep 30, 2023 | 31,000.00 |